Radiotherapy for oligometastatic disease in patients with spinal cord compression (MSCC) from relatively radioresistant tumors.
Related Research units
Abstract
Radiotherapy alone is the most common treatment for metastatic spinal cord compression (MSCC). Patients with relatively radioresistant tumors and oligometastatic disease may benefit from more intensive therapies (surgery, high-precision radiotherapy). If such therapies are not available, one can speculate whether patients benefit from dose escalation beyond the standard regimen 30 Gy in ten fractions.
Bibliographical data
| Original language | German |
|---|---|
| Article number | 4 |
| ISSN | 0179-7158 |
| Publication status | Published - 2010 |
| pubmed | 20354660 |
|---|
